Followers | 261 |
Posts | 51308 |
Boards Moderated | 17 |
Alias Born | 08/29/2007 |
![](https://investorshub.advfn.com/uicon/108458.png?cb=1482855649)
Friday, March 15, 2024 2:57:52 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent IMRX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:20:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:09:51 PM
- Immuneering to Present at the Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/29/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2024 08:20:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2024 08:18:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2024 08:15:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2024 08:14:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 08:10:44 PM
- Immuneering Reports First Quarter 2024 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 05/07/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:04:07 PM
- Immuneering Recognizes Melanoma Awareness Month • GlobeNewswire Inc. • 05/06/2024 08:30:00 PM
- IMM-1-104 is Synergistic with Chemotherapy in Pancreatic Cancer Models • GlobeNewswire Inc. • 04/09/2024 04:00:00 PM
- Immuneering to Participate in the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/03/2024 08:05:00 PM
- Immuneering Announces First Patient Dosed in its Phase 1/2a Trial of IMM-6-415 to Treat Advanced Solid Tumors with RAF or RAS Mutations • GlobeNewswire Inc. • 03/27/2024 12:00:00 PM
- Immuneering Announces Positive Topline Results from Phase 1 Portion of its Phase 1/2a Clinical Trial of IMM-1-104 in RAS-Mutant Solid Tumors • GlobeNewswire Inc. • 03/14/2024 11:00:00 AM
- Immuneering Appoints Thomas J. Schall, Ph.D. to its Board of Directors • GlobeNewswire Inc. • 03/12/2024 12:00:00 PM
- Immuneering Doses First Patient in Phase 2a Clinical Trial of IMM-1-104 in RAS-mutant Solid Tumors • GlobeNewswire Inc. • 03/11/2024 12:00:00 PM
- Immuneering to Present Preclinical Data on Universal-RAS Program IMM-1-104 at American Association for Cancer Research Annual Meeting 2024 • GlobeNewswire Inc. • 03/05/2024 10:00:00 PM
- Immuneering to Participate in the Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 03/04/2024 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/01/2024 01:05:34 PM
- Immuneering Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 03/01/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 12:58:59 PM
- Immuneering Receives FDA Fast Track Designation for IMM-1-104 in Pancreatic Cancer • GlobeNewswire Inc. • 02/20/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:26:08 PM
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM